Editorial Team

Shanker Gupta, PhD, Editor-In-Chief

Dr. Gupta has been a member of the Journal Editorial Board since 2019 and, most recently, has served as an Associate Editor, helping evaluating and managing JPST submissions. He has been a PDA member for more than 30 years. Dr. Gupta has worked with the National Institutes of Health for almost 20 years, currently as a senior scientist in the Division of Cancer Prevention of the National Cancer Institute and consulting with the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases. At NIH, he has been responsible for managing multiple translational projects designed to generate clinical product for use in Phase I and Phase 2 clinical trials. Dr. Gupta also collaborates with contract teams and actively participates in the design and development of formulations of several promising agents that have resulted in patent filings. He has supported over 40 IND submissions. Dr. Gupta holds a BS (Hons) in pharmacy from the University of Florida and a PhD in pharmaceutical chemistry from the University of Michigan, Ann Arbor. Prior to joining NIH, he was a project leader in sterile products development at Abbott Laboratories and filed the IND for the expanded use of a lung surfactant product (Survanta^®), which was the first product of its kind for neonatal respiratory distress syndrome. Gupta has published more than 20 papers in various peer-reviewed journals and contributed to books. 

PDA, Inc., Leadership 

Chair 

Anil Sawant, PhD, Merck & Co., Inc./Merck Sharp & Dohme 

Chair-elect 

Melissa Seymour, Bristol Myers Squibb

Treasurer 

Emma Ramnarine, PhD, Boehringer-Ingelheim

Secretary 

Bettine Boltres, PhD, West Pharmaceutical Services

Immediate Past Chair  

Susan Schniepp, Regulatory Compliance Associates Inc. 

Directors 

PDA Staff Liaisons 

Walter Morris, Sr. Director, Publishing & Press Relations 

Whitney Alexis, Editorial Assistant